{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:45:36Z","timestamp":1790127936987,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00335-024-10085-w","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T19:13:50Z","timestamp":1732130030000},"page":"213-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Impact of IL-6 rs1800795 and rs1800796 polymorphisms on clinical outcomes of COVID-19: a study on severity of disease in Turkish population"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1000-7842","authenticated-orcid":false,"given":"Nilgun","family":"Cekin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-6091","authenticated-orcid":false,"given":"Seyda","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3863-9470","authenticated-orcid":false,"given":"Ergun","family":"Pinarbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-0760","authenticated-orcid":false,"given":"Okan Halef","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"10085_CR1","doi-asserted-by":"publisher","unstructured":"Abobaker A, Nagib T, Alsoufi A (2021) The impact of certain genetic variants (single nucleotide polymorphisms) on incidence and severity of COVID-19. J Gene Med. 2021;23(2):e3310. https:\/\/doi.org\/10.1002\/jgm.3310","DOI":"10.1002\/jgm.3310"},{"key":"10085_CR3","doi-asserted-by":"publisher","unstructured":"Babu BM, Reddy BP, Priya VH et al (2012) Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. Genet Test Mol Biomarkers. 2012;16(5):359\u2013365. https:\/\/doi.org\/10.1089\/gtmb.2011.0182","DOI":"10.1089\/gtmb.2011.0182"},{"key":"10085_CR4","doi-asserted-by":"publisher","unstructured":"Bouhniz OE, Zaied S, Naija L et al (2020) Association between HER2 and IL-6 genes polymorphisms and clinicopathological characteristics of breast cancer: significant role of genetic variability in specific breast cancer subtype. Clin Exp Med. 2020;20(3):427\u2013436. https:\/\/doi.org\/10.1007\/s10238-020-00632-5","DOI":"10.1007\/s10238-020-00632-5"},{"key":"10085_CR5","doi-asserted-by":"publisher","unstructured":"Broman N, Rantas\u00e4rkk\u00e4 K, Feuth T et al (2021) IL-6 and other biomarkers as predictors of severity in COVID-19. Ann Med. 2021;53(1):410\u2013412. https:\/\/doi.org\/10.1080\/07853890.2020.1840621","DOI":"10.1080\/07853890.2020.1840621"},{"issue":"125","key":"10085_CR6","doi-asserted-by":"publisher","first-page":"e0137221","DOI":"10.1128\/mBio.01372-21","volume":"2021","author":"T Chen","year":"2021","unstructured":"Chen T, Lin YX, Zha Y et al (2021a) A low-producing haplotype of Interleukin-6 disrupting CTCF binding is protective against severe COVID-19. mBio 2021(125):e0137221. https:\/\/doi.org\/10.1128\/mBio.01372-21","journal-title":"mBio"},{"key":"10085_CR7","doi-asserted-by":"publisher","unstructured":"Chen Z, Xu W, Ma W et al (2021b) Clinical laboratory evaluation of COVID-19. Clin Chim Acta. 2021;519:172\u2013182. https:\/\/doi.org\/10.1016\/j.cca.2021.04.022","DOI":"10.1016\/j.cca.2021.04.022"},{"key":"10085_CR9","doi-asserted-by":"publisher","unstructured":"Daga S, Fallerini C, Baldassarri M et al (2021) Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research. Eur J Hum Genet. 2021;29(5):745\u2013759. https:\/\/doi.org\/10.1038\/s41431-020-00793-7","DOI":"10.1038\/s41431-020-00793-7"},{"key":"10085_CR11","doi-asserted-by":"publisher","unstructured":"Deng Y, Liu W, Liu K et al (2020) Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020;133(11):1261\u20131267. https:\/\/doi.org\/10.1097\/CM9.0000000000000824","DOI":"10.1097\/CM9.0000000000000824"},{"key":"10085_CR10","doi-asserted-by":"publisher","unstructured":"Deng X, Tang K, Wang Z, He S, Luo Z (2024) Impacts of Inflammatory Cytokines Variants on Systemic Inflammatory Profile and COVID-19 Severity. J Epidemiol Glob Health. 2024;14(2):363\u2013378. https:\/\/doi.org\/10.1007\/s44197-024-00204-w","DOI":"10.1007\/s44197-024-00204-w"},{"key":"10085_CR12","doi-asserted-by":"publisher","unstructured":"El-Bendary M, Naemattalah M, Elalfy H et al (2024) Association of Interleukin-6 (rs1800795) and Interleukin-10 (rs1800896) Genetic Polymorphisms with the Outcome of COVID-19 Infection: A Single Center Study. Viral Immunol. 2024;37(5):251\u2013258. https:\/\/doi.org\/10.1089\/vim.2024.0029","DOI":"10.1089\/vim.2024.0029"},{"key":"10085_CR13","doi-asserted-by":"publisher","unstructured":"Falahi S, Zamanian MH, Feizollahi P et al (2022) Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population. Cytokine. 2022;154:155889. https:\/\/doi.org\/10.1016\/j.cyto.2022.155889","DOI":"10.1016\/j.cyto.2022.155889"},{"key":"10085_CR14","doi-asserted-by":"publisher","unstructured":"Ghazy AA (2023) Influence of IL-6 rs1800795 and IL-8 rs2227306 polymorphisms on COVID-19 outcome. J Infect Dev Ctries. 2023;17(3):327\u2013334. Published 2023 Mar 31. https:\/\/doi.org\/10.3855\/jidc.17717","DOI":"10.3855\/jidc.17717"},{"key":"10085_CR15","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Castro TB, Hern\u00e1ndez-D\u00edaz Y, P\u00e9rez-Hern\u00e1ndez N et al (2019) Interleukin 6 (rs1800795) gene polymorphism is associated with cardiovascular diseases: a meta-analysis of 74 studies with 86,229 subjects. EXCLI J. 2019;18:331\u2013355. Published 2019 Jun 7. https:\/\/doi.org\/10.17179\/excli2019-1248","DOI":"10.17179\/excli2019-1248"},{"key":"10085_CR16","doi-asserted-by":"crossref","unstructured":"Gorbalenyaz AE, Baker SC, Baric RS et al (2020) Severe acute respiratory syndrome-related coronavirus: The species and its viruses\u2013astatement of the Coronavirus Stuy Group. BioRxiv, 2020; 2020:2002\u20132007","DOI":"10.1101\/2020.02.07.937862"},{"key":"10085_CR17","doi-asserted-by":"publisher","unstructured":"Goyenechea E, Parra D, Mart\u00ednez JA (2007) Impact of interleukin 6 -174G\u2009>\u2009C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism. 2007;56(12):1643\u20131648. https:\/\/doi.org\/10.1016\/j.metabol.2007.07.005","DOI":"10.1016\/j.metabol.2007.07.005"},{"key":"10085_CR18","doi-asserted-by":"publisher","unstructured":"Guan WJ, Ni ZY, Hu Y et al (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","DOI":"10.1056\/NEJMoa2002032"},{"key":"10085_CR19","doi-asserted-by":"publisher","unstructured":"He JQ, Foreman MG, Shumansky K et al (2009) Associations of IL6 polymorphisms with lung function decline and COPD. Thorax. 2009;64(8):698\u2013704. https:\/\/doi.org\/10.1136\/thx.2008.111278","DOI":"10.1136\/thx.2008.111278"},{"key":"10085_CR6020","doi-asserted-by":"publisher","unstructured":"Heidari Nia M, Rokni M, Mirinejad S et al (2022) Association of polymorphisms in tumor necrosis factors withSARS-CoV-2 infection and mortality rate: a case-control study and in silico analyses. J Med Virol 94(4):1502\u20131512. https:\/\/doi.org\/10.1002\/jmv.27477","DOI":"10.1002\/jmv.27477"},{"key":"10085_CR20","doi-asserted-by":"publisher","unstructured":"Hirano T (2021) IL-6 in inflammation, autoimmunity, and cancer. Int Immunol. 2021;33(3):127\u2013148. https:\/\/doi.org\/10.1093\/intimm\/dxaa078","DOI":"10.1093\/intimm\/dxaa078"},{"key":"10085_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/324073a0","volume":"324","author":"T Hirano","year":"1986","unstructured":"Hirano T, Yasukawa K, Harada H et al (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73","journal-title":"Nature"},{"key":"10085_CR22","doi-asserted-by":"publisher","unstructured":"Hong LZ, Shou ZX, Zheng DM, Jin X (2021) The most important biomarker associated with coagulation and inflammation among COVID-19 patients. Mol Cell Biochem. 2021;476(7):2877\u20132885. https:\/\/doi.org\/10.1007\/s11010-021-04122-4","DOI":"10.1007\/s11010-021-04122-4"},{"key":"10085_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93:250 [PMC free article] [PubMed] [Google Scholar]","journal-title":"J Med Virol"},{"key":"10085_CR24","doi-asserted-by":"publisher","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020;:]. Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","DOI":"10.1016\/S0140-6736(20)30183-5"},{"issue":"4","key":"10085_CR25","doi-asserted-by":"publisher","first-page":"piiE372","DOI":"10.3390\/v12040372","volume":"12","author":"Y Jin","year":"2020","unstructured":"Jin Y, Yang H, Ji W et al (2020) Virology, epidemiology, pathogenesis and control of COVID19. Viruses 12(4):piiE372","journal-title":"Viruses"},{"key":"10085_CR26","doi-asserted-by":"publisher","unstructured":"Jones SA, Hunter CA (2021) Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol. 2021;21(6):337\u2013339. https:\/\/doi.org\/10.1038\/s41577-021-00553-8","DOI":"10.1038\/s41577-021-00553-8"},{"key":"10085_CR27","doi-asserted-by":"publisher","unstructured":"Karcioglu Batur L, Hekim N (2021) Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. J Med Virol. 2021;93(10):5853\u20135863. https:\/\/doi.org\/10.1002\/jmv.27127","DOI":"10.1002\/jmv.27127"},{"key":"10085_CR28","doi-asserted-by":"crossref","unstructured":"Kerget F, Kerget B (2021) Frequency of Interleukin-6 rs1800795 (-174G\/C) and rs1800797 (-597G\/A) polymorphisms in COVID-19 patients in turkey who develop macrophage activation syndrome Jpn J. Infect. Dis., 74 (6) (2021), pp. 543\u2013548","DOI":"10.7883\/yoken.JJID.2021.046"},{"key":"10085_CR29","doi-asserted-by":"publisher","unstructured":"Khafaei M, Asghari R, Zafari F, Sadeghi M (2024) Impact of IL-6 rs1800795 and IL-17A rs2275913 gene polymorphisms on the COVID-19 prognosis and susceptibility in a sample of Iranian patients. Cytokine. 2024;174:156445. https:\/\/doi.org\/10.1016\/j.cyto.2023.156445","DOI":"10.1016\/j.cyto.2023.156445"},{"issue":"12","key":"10085_CR30","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1080\/07391102.2020.1776640","volume":"39","author":"N Kirtipal","year":"2021","unstructured":"Kirtipal N, Bharadwaj S (2021) Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans. J Biomol Struct Dyn 39(12):4563\u20134565. https:\/\/doi.org\/10.1080\/07391102.2020.1776640","journal-title":"J Biomol Struct Dyn"},{"key":"10085_CR31","doi-asserted-by":"crossref","unstructured":"Kishimoto T (2005) Interleukin-6: from basic science to medicine- 40 years in immunology. Annu Rev Immunol. 2005;23:1\u201321","DOI":"10.1146\/annurev.immunol.23.021704.115806"},{"issue":"1","key":"10085_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12881-019-0768-0","volume":"20","author":"C Konwar","year":"2019","unstructured":"Konwar C, Gobbo D, Terry GF, J., Robinson WP (2019) Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis. BMC Med Genet 20(1):36. https:\/\/doi.org\/10.1186\/s12881-019-0768-0","journal-title":"BMC Med Genet"},{"key":"10085_CR34","doi-asserted-by":"crossref","unstructured":"Li X, Ma X (2020) Acute Respiratory Failure in COVID-19: Is it Typical ARDS? Crit Care [Internet]. 2020. [(accessed on 27 May 2021)]; Available online","DOI":"10.1186\/s13054-020-02911-9"},{"key":"10085_CR33","doi-asserted-by":"publisher","unstructured":"Li M, Zhuo Y, Xu Y, Chen H, Cheng Z, Zhou L (2021) Genetic Association of Interleukin-6 Polymorphism (rs1800796) with Chronic Hepatitis B Virus Infection in Chinese Han Population. Viral Immunol. 2021;34(4):267\u2013272. https:\/\/doi.org\/10.1089\/vim.2020.0211","DOI":"10.1089\/vim.2020.0211"},{"key":"10085_CR35","doi-asserted-by":"publisher","unstructured":"Lippi G, Favaloro EJ (2020) D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis. Thromb Haemost. 2020;120(5):876\u2013878. https:\/\/doi.org\/10.1055\/s-0040-1709650","DOI":"10.1055\/s-0040-1709650"},{"key":"10085_CR36","doi-asserted-by":"crossref","unstructured":"Lu L, Zhang H, Zhan M et al (2020) Preventing mortality in COVID-19 patients: which cytokine to target in a raging storm? Front Cell Dev Biol. 2020;8:677","DOI":"10.3389\/fcell.2020.00677"},{"key":"10085_CR37","doi-asserted-by":"crossref","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) HLH Across Speciality Collaboration, UK. 2020. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033","DOI":"10.1016\/S0140-6736(20)30628-0"},{"key":"10085_CR38","doi-asserted-by":"publisher","first-page":"107364","DOI":"10.1016\/j.intimp.2020.107364","volume":"93","author":"L Mohamed Khosroshahi","year":"2021","unstructured":"Mohamed Khosroshahi L, Rokni M, Mokhtari T, Noorbakhsh F (2021) Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview. Int Immunopharmacol 93:107364. https:\/\/doi.org\/10.1016\/j.intimp.2020.107364","journal-title":"Int Immunopharmacol"},{"key":"10085_CR39","doi-asserted-by":"publisher","unstructured":"Montero P, Milara J, Roger I, Cortijo J (2021) Role of JAK\/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms. Int J Mol Sci. 2021;22(12):6211. Published 2021 Jun 9. https:\/\/doi.org\/10.3390\/ijms22126211","DOI":"10.3390\/ijms22126211"},{"key":"10085_CR40","doi-asserted-by":"publisher","unstructured":"Murakami M, Hirano T (2012) The pathological and physiological roles of IL-6 amplifier activation. Int J Biol Sci. 2012;8(9):1267\u20131280. https:\/\/doi.org\/10.7150\/ijbs.4828","DOI":"10.7150\/ijbs.4828"},{"key":"10085_CR41","doi-asserted-by":"publisher","unstructured":"Noureddine R, Baba H, Aqillouch S et al (2024) The Interleukin-6 gene variants may protect against SARS-CoV-2 infection and the severity of COVID-19: a case-control study in a Moroccan population. BMC Med Genomics. 2024;17(1):139. Published 2024 May 23. https:\/\/doi.org\/10.1186\/s12920-024-01911-w","DOI":"10.1186\/s12920-024-01911-w"},{"key":"10085_CR42","doi-asserted-by":"publisher","unstructured":"Pourroostaei Ardakani P, Abkhiz S, Sheykhi K et al (2023) Molecular Investigation of the Association Among Common Interleukin-6 Polymorphism and Human Papillomavirus Genotypes with Cervical Cancer Among Iranian Women. Monoclon Antib Immunodiagn Immunother. 2023;42(4):125\u2013131. https:\/\/doi.org\/10.1089\/mab.2022.0039","DOI":"10.1089\/mab.2022.0039"},{"key":"10085_CR43","doi-asserted-by":"publisher","unstructured":"Riazalhosseini B, Mohamed Z, Apalasamy YD, Shafie NS, Mohamed R (2018) Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population. Biomed Rep. 2018;9(3):213\u2013220. https:\/\/doi.org\/10.3892\/br.2018.1126","DOI":"10.3892\/br.2018.1126"},{"key":"10085_CR44","doi-asserted-by":"publisher","unstructured":"Rodrigues FBB, da Silva R, Santos EFD et al (2023) Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population. Viruses. 2023;15(5):1197. Published 2023 May 19. https:\/\/doi.org\/10.3390\/v15051197","DOI":"10.3390\/v15051197"},{"issue":"10","key":"10085_CR45","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1080\/21645515.2020.1799669","volume":"16","author":"M Rokni","year":"2020","unstructured":"Rokni M, Hamblin MR, Rezaei N (2020a) Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother 16(10):2363\u20132365. https:\/\/doi.org\/10.1080\/21645515.2020.1799669Epub 2020 Aug 25. PMID: 32841579; PMCID: PMC7644241","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10085_CR46","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1186\/s12879-020-05540-3","volume":"20","author":"M Rokni","year":"2020","unstructured":"Rokni M, Ahmadikia K, Asghari S, Mashaei S, Hassanali F (2020b) Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness. BMC Infect Dis 20(1):869. https:\/\/doi.org\/10.1186\/s12879-020-05540-3","journal-title":"BMC Infect Dis"},{"key":"10085_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/cpt.782","volume":"102","author":"S Rose-John","year":"2017","unstructured":"Rose-John S (2017) The soluble interleukin 6 receptor: advanced therapeutic options in inflammation. Clin Pharmacol Ther 102:591","journal-title":"Clin Pharmacol Ther"},{"key":"10085_CR47","doi-asserted-by":"publisher","unstructured":"Rose-John S, Jenkins BJ, Garbers C, Moll JM, Scheller J (2023) Targeting IL-6 trans-signalling: past, present and future prospects. Nat Rev Immunol. 2023;23(10):666\u2013681. https:\/\/doi.org\/10.1038\/s41577-023-00856-y","DOI":"10.1038\/s41577-023-00856-y"},{"key":"10085_CR50","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2020.04.008","volume":"92","author":"X Sawkulycz","year":"2020","unstructured":"Sawkulycz X, Bradburn S, Robinson A, Payton A, Pendleton N, Murgatroyd C (2020) Regulation of interleukin 6 by a polymorphic CpG within the frontal cortex in Alzheimer\u2019s disease. Neurobiol Aging 92:75\u201381. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.04.008","journal-title":"Neurobiol Aging"},{"key":"10085_CR51","doi-asserted-by":"publisher","unstructured":"Shoily SS, Ahsan T, Fatema K, Sajib AA (2021) Common genetic variants and pathways in diabetes and associated complications and vulnerability of populations with different ethnic origins. Sci Rep. 2021;11(1):7504. Published 2021 Apr 5. https:\/\/doi.org\/10.1038\/s41598-021-86801-2","DOI":"10.1038\/s41598-021-86801-2"},{"issue":"15","key":"10085_CR53","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinf (Oxford England) 22(15):1928\u20131929. https:\/\/doi.org\/10.1093\/bioinformatics\/btl268","journal-title":"Bioinf (Oxford England)"},{"key":"10085_CR54","doi-asserted-by":"publisher","unstructured":"Tabrez S, Jabir NR, Zughaibi TA, Suhail M (2022) Association of IL-6 promoter polymorphism hotspots (\u2013\u2009174G\/C and\u2013\u2009572G\/C) with cardiovascular disease risk factors. Mol Biol Rep. 2022;49(3):2265\u20132272. https:\/\/doi.org\/10.1007\/s11033-021-07048-8","DOI":"10.1007\/s11033-021-07048-8"},{"key":"10085_CR55","doi-asserted-by":"publisher","unstructured":"Terpos E, Ntanasis-Stathopoulos I, Elalamy I et al (2020) Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834\u2013847. https:\/\/doi.org\/10.1002\/ajh.25829","DOI":"10.1002\/ajh.25829"},{"key":"10085_CR57","doi-asserted-by":"publisher","unstructured":"Verma S, Verma S, Khan FH et al (2023) Genetic polymorphisms of IL6 gene\u2013\u2009174G\u2009>\u2009C and\u2013\u2009597G\u2009>\u2009A are associated with the risk of COVID-19 severity. Int J Immunogenet. 2023;50(1):5\u201311. https:\/\/doi.org\/10.1111\/iji.12605","DOI":"10.1111\/iji.12605"},{"key":"10085_CR58","doi-asserted-by":"crossref","unstructured":"Wan S, Yi Q, Fan S et al (2019) Relationship among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. BJHaem, 2019; 189(3):428\u2013437","DOI":"10.1111\/bjh.16659"},{"key":"10085_CR59","doi-asserted-by":"publisher","unstructured":"Young BE, Ong SWX, Kalimuddin S et al (2020) Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore [published correction appears in JAMA. 2020;323(15):1510]. JAMA. 2020;323(15):1488\u20131494. https:\/\/doi.org\/10.1001\/jama.2020.3204","DOI":"10.1001\/jama.2020.3204"},{"key":"10085_CR61","doi-asserted-by":"publisher","unstructured":"Zhou L, Zheng Y, Tian T, Liu K, Wang M, Lin S et al (2018) Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls. Gene. 2018;670:136\u2013147. https:\/\/doi.org\/10.1016\/j.gene.2018.05.104","DOI":"10.1016\/j.gene.2018.05.104"},{"key":"10085_CR60","doi-asserted-by":"publisher","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"10085_CR62","doi-asserted-by":"crossref","unstructured":"Zhu N et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020; 382:727\u2013733","DOI":"10.1056\/NEJMoa2001017"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-024-10085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-024-10085-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-024-10085-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T06:47:31Z","timestamp":1741157251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-024-10085-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10085"],"URL":"https:\/\/doi.org\/10.1007\/s00335-024-10085-w","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the author(s) used Wordvice (.) in order to English Grammar Checking. After using this tool\/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies"}}]}}